Trial Profile
Clinical Trial to Investigate the Safety and Pharmacokinetics/Pharmacodynamics of CKD-841 After Subcutaneous Injection in Postmenopausal Female
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary)
- Indications Cancer
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Chong Kun Dang
- 03 Aug 2017 New trial record